Scottish Centre for Telehealth and Telecare

Main Achievements

• U4H has enabled the redesign of care processes and the integration of telehealth into routine care. It has been a complex and time consuming process but deployment sites have shown that it is possible to deploy telehealth at scale.

• U4H demonstrated that telehealth is as safe as routine care, and has provided evidence of clinical benefits. It has also demonstrated that citizens are receptive to the use of telehealth and remote monitoring services.

• A total of 6,902 citizens received a telehealth service, with data on 4,509 patients evaluated, making it one of the largest studies of telehealth in Europe.

• U4H has gathered its lessons-learned and produced guidelines for the procurement and implementation of telehealth based on real life experiences.

• 90% of U4H services continued running after the evaluation ended, and further scaling up is in process within most U4H regions.

image: Main Project Outcomes

Diabetes

Clinical

The primary outcome of this study was a reduction in the number of face-to-face contacts with a GP or Diabetologist. The results evidence that the number of face-to face contacts is lower in the telemonitoring group than in the comparator group, although not at a level which is considered statistically significant.
Secondary outcomes identified that the number of admissions to hospital is lower in the telehealth group and the reduction in HbA1c is bigger in the telehealth group. Both of these are at statistically significant levels.

Economic

Economic analysis results demonstrate that the telehealth intervention overall in the diabetes trial increased the average costs per patients. However, for some regions using web based, patient facing online digital technologies (Scotland, Wales, Finland and Italy) there was a reduction in total costs. Telemonitoring for diabetes for these regions, including Scotland was cost effective. The way in which telehealth services are organised and the type of ICT solutions used are significant determinants of cost effectiveness.

The full evaluation report is available for review here.

 

image: Main Project Outcomes

Chronic Obstructive Pulmonary Disease

Clinical

The project concluded that telemonitoring is safe and popular with users, confers some clinical benefit, but most probably in the longer term. It is least effective when offered to patients immediately following acute hospital admission(s) for COPD .  However, it has been shown in this study  to be beneficial for post –discharge patients once the condition has stabilised.

Economic

The economic analysis demonstrated that telehealth intervention for the COPD cohort did lead to a reduction in the average costs per patient. This was largely attributed to an overall reduction in the number of admissions over the 3 month period. Cost variations were found between the six european regions involved, but all regions were able to demonstrate a reduction in the costs per patient using telehealth.

The full evaluation report is available here.

 

 

image: Main Project Outcomes

Congestive Heart Failure

Clinical

The study found that overall telehealth is a key enabler to improving co-ordination, empowerment, treatment adherence, and anticipatory care for CHF patients.
Patients in the intervention group achieved better results than the comparator group in nearly all primary and secondary outcomes. The telemonitoring group of users presented with lower mortality and hospitalisation rates, however this was not at a level which is considered statistically significant.

Economic

The analysis of all European data showed that telehealth interventions in the CHF trial reduced the average costs per patient mainly because one region ( Scotland) was able to demonstrate a reduction in costs. In the other three regions, the costs savings per patient were less.
All sites reported that there was generally good levels of satisfaction with the telehealth solution. Whilst not directly felt to save time initially, staff reported increased productivity once services were embedded into routine care.

The full evaluation report is available here.

 

 

Latest News

latest news
Innovate UK – Digital health technology catalyst 2017 round 1 Competition opens: Monday 31 July 2017
Competition closes: Wednesday 11 October 2017 12:00pm [more]
Launch of the iHub Improvement Fund The application acceptance period is between 1st - 22nd September 2017. [more]